Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Current Drug Abuse Reviews|July 28, 2009
Potential role of ADAMTS13 in the progression of alcoholic hepatitisMasahito Uemura, Yoshihiro Fujimura, Tomomi Matsuyama, et al.
Journal of Angiogenesis Research|August 25, 2010
The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failureTadashi Namisaki, Hitoshi Yoshiji, Ryuichi Noguchi, et al.
Oncology Reports|April 6, 2005
Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tractShigeki Kuriyama, Hitoshi Yoshiji, Akihiro Deguchi, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 5, 2011
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in ratsKosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade, et al.
International Journal of Oncology|December 22, 2007
Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularizationRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
Internal Medicine (Tokyo, Japan)|August 6, 2010
Pneumatosis cystoides intestinalis induced by the α-glucosidase inhibitor miglitolKuniyuki Kojima, Tatsuhiro Tsujimoto, Hisao Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2010
Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in miceKosuke Kaji, Hitoshi Yoshiji, Mitsuteru Kitade, et al.
Alcoholism, Clinical and Experimental Research|December 20, 2008
Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemiaMasatoshi Ishikawa, Masahito Uemura, Tomomi Matsuyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2006
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis developmentHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.
International Journal of Molecular Medicine|July 29, 2010
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in ratsRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
Pageof 6